Pulmatrix, Inc. is a clinical-stage biopharmaceutical company based in Lexington, Massachusetts, focused on the discovery and development of innovative inhaled therapies aimed at addressing respiratory diseases and other serious conditions with significant unmet medical needs. With a strong commitment to advancing its proprietary методы and technologies, Pulmatrix is positioned to deliver transformative treatments that enhance patient outcomes and quality of life. The company leverages its extensive expertise in inhalation drug delivery to create solutions that target vital therapeutic areas, positioning itself as a key player in the evolving landscape of respiratory medicine.